These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3864367)

  • 1. Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
    Bosso JA; Townsend RJ
    Am J Hosp Pharm; 1985 Oct; 42(10):2211-4. PubMed ID: 3864367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of clindamycin phosphate with cefotaxime sodium or netilmicin sulfate in small-volume admixtures.
    Foley PT; Bosso JA; Bair JN; Townsend RJ
    Am J Hosp Pharm; 1985 Apr; 42(4):839-43. PubMed ID: 4014236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of cefamandole nafate and cefoxitin sodium solutions.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1981 Jun; 38(6):875-9. PubMed ID: 7246563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
    Marble DA; Bosso JA; Townsend RJ
    Am J Hosp Pharm; 1986 Jul; 43(7):1732-6. PubMed ID: 3529949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of frozen solutions of cefamandole nafate.
    Bornstein M; Klink PR; Farrell BT; Winely CL; Boylan JC
    Am J Hosp Pharm; 1980 Jan; 37(1):98-101. PubMed ID: 7361780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoxitin sodium compatibility with intravenous infusions and additives.
    O'Brien MJ; Portnoff JB; Cohen EM
    Am J Hosp Pharm; 1979 Jan; 36(1):33-8. PubMed ID: 31790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.
    Stiles ML; Tu YH; Allen LV
    Am J Hosp Pharm; 1989 Jul; 46(7):1408-12. PubMed ID: 2667354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of intravenous admixtures of aztreonam and clindamycin phosphate.
    James MJ; Riley CM
    Am J Hosp Pharm; 1985 Sep; 42(9):1984-6. PubMed ID: 4050817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronidazole, or tobramycin.
    Bell RG; Lipford LC; Massanari MJ; Riley CM
    Am J Hosp Pharm; 1986 Jun; 43(6):1444-53. PubMed ID: 3728479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility and stability of cefazolin sodium, clindamycin phosphate, and gentamicin sulfate in two intravenous solutions.
    Zbrozek AS; Marble DA; Bosso JA
    Drug Intell Clin Pharm; 1988 Nov; 22(11):873-5. PubMed ID: 3234252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of intravenous admixtures containing aztreonam and cefazolin.
    Riley CM; James MJ
    Am J Hosp Pharm; 1986 Apr; 43(4):925-7. PubMed ID: 3706339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of cefamandole nafate injection with parenteral solutions and additives.
    Frable RA; Klink PR; Engel GL; Mundell EE
    Am J Hosp Pharm; 1982 Apr; 39(4):622-7. PubMed ID: 7082453
    [No Abstract]   [Full Text] [Related]  

  • 13. Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
    Marble DA; Bosso JA; Townsend RJ
    Drug Intell Clin Pharm; 1988 Jan; 22(1):54-7. PubMed ID: 3349921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of ciprofloxacin injection with selected drugs and solutions.
    Goodwin SD; Nix DE; Heyd A; Wilton JH
    Am J Hosp Pharm; 1991 Oct; 48(10):2166-71. PubMed ID: 1781473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of frozen solutions of cefazolin sodium.
    Carone SM; Bornstein M; Coleman DL; Thomas PN; Boylan JC
    Am J Hosp Pharm; 1976 Jul; 33(7):639-41. PubMed ID: 7955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5% dextrose injections.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1984 Apr; 41(4):686-9. PubMed ID: 6720710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inactivation of tobramycin by cephalosporins.
    Spruill WJ; McCall CY; Francisco GE
    Am J Hosp Pharm; 1985 Nov; 42(11):2506-9. PubMed ID: 3907338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
    Cheung YW; Cradock JC; Vishnuvajjala BR; Flora KP
    Am J Hosp Pharm; 1987 Jan; 44(1):124-30. PubMed ID: 3548341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.